Cannabidiol (CBD), a compound found in cannabis plants, has attracted growing interest in wellness products marketed for concerns such as anxiety, pain and sleep. However, evidence supporting these uses remains limited, and health authorities warn that products sold outside regulated medical settings may carry risks.
Unlike tetrahydrocannabinol (THC), the cannabis compound primarily responsible for the intoxicating effects associated with marijuana, CBD does not typically produce a high. That distinction does not mean all CBD products are safe or that claims made about them are medically established.
What is CBD, and what does the evidence show?
CBD is one of the cannabinoids found in cannabis plants. It is sold in various forms, including oils, capsules, creams and food products. Some manufacturers market it for anxiety, pain, sleep problems and other conditions, but the evidence varies by condition and product.
The US Food and Drug Administration (FDA) has approved a prescription CBD medicine for seizures associated with three conditions: Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. That approval does not extend to the wider range of CBD oils, supplements and wellness products sold to consumers.
The World Health Organization has reported that pure CBD does not appear to have the same potential for abuse or dependence as some other cannabis-related substances. However, this finding should not be taken to mean that every product labelled CBD is harmless.
Safety concerns and unproven claims
CBD can cause side effects, including drowsiness and gastrointestinal problems. The FDA also warns that it may damage the liver and interact with medicines, potentially changing how they work.
The risks are particularly important when products are taken without medical supervision or when their ingredients and concentrations are uncertain. Products marketed online may contain different amounts of CBD from those stated on their labels, and some may contain THC or other unwanted substances.
Claims that CBD reliably treats anxiety, chronic pain or insomnia should therefore be approached cautiously. Evidence for one medical application does not establish that CBD is effective for every condition for which it is advertised.
There is also no basis in the supplied material for the claim that young people are widely using CBD or that particular individuals have benefited from it. No personal accounts, survey figures or independent evidence were provided to support those assertions.
Legal status depends on the country
CBD’s legal status cannot be determined by its chemical properties alone. Laws may distinguish between cannabis-derived substances, products containing THC and medicines authorised for specific purposes.
In Uganda, the Narcotic Drugs and Psychotropic Substances (Control) Act, 2024, provides a legal framework governing cannabis and related substances. The legislation defines cannabis and cannabis oil and regulates prohibited plants, subject to the exceptions and licensing provisions set out in the law. The legality of a particular CBD product should not be assumed without checking the applicable provisions and regulatory requirements.
The legal position in the United States is different. Although federal law distinguishes hemp from marijuana according to THC content, CBD products remain subject to applicable food and drug regulations. The FDA has not approved CBD as a general dietary supplement or as an ingredient that can be freely added to food.
Medical advice and product quality
People considering CBD for a health condition should consult a qualified healthcare professional before using it, particularly if they take other medicines. CBD should not replace prescribed treatment on the strength of marketing claims.
The original material recommends checking independent laboratory testing and product labelling. These checks may help establish what a product contains, but they do not prove that it is effective or safe for a particular person.
The central distinction is between a compound with potential medical applications and a commercial product whose quality, dosage, safety and effectiveness may not have been established.
Editorial note: The supplied article does not contain original interviews, documented personal experiences, sales figures or evidence that CBD use is increasing among young people. Those claims have not been presented as established facts in this version.
